|
1.
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
|
|
2.
|
Brenner H, Rothenbacher D and Arndt V:
Epidemiology of stomach cancer. Methods Mol Biol. 472:467–477.
2009. View Article : Google Scholar
|
|
3.
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics for Hispanics/Latinos, 2012. CA Cancer J Clin.
62:283–298. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Chandanos E and Lagergren J: Oestrogen and
the enigmatic male predominance of gastric cancer. Eur J Cancer.
44:2397–2403. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006.
|
|
6.
|
Kelley JR and Duggan JM: Gastric cancer
epidemiology and risk factors. J Clin Epidemiol. 56:1–9. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Lindblad M, Rodriguez LA and Lagergren J:
Body mass, tobacco and alcohol and risk of esophageal, gastric
cardia, and gastric non-cardia adenocarcinoma among men and women
in a nested case-control study. Cancer Causes Control. 16:285–294.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Parkin DM, Whelan SL, Ferlay J, et al:
Cancer incidence in five continents. VIII. IARC Press; Lyon: pp.
1–781. 2002
|
|
9.
|
Sipponen P and Correa P: Delayed rise in
incidence of gastric cancer in females results in unique sex ratio
(M/F) pattern: etiologic hypothesis. Gastric Cancer. 5:213–219.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Fernandez E, Gallus S, Bosetti C, et al:
Hormone replacement therapy and cancer risk: a systematic analysis
from a network of case-control studies. Int J Cancer. 105:408–412.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Frise S, Kreiger N, Gallinger S, et al:
Menstrual and reproductive risk factors and risk for gastric
adenocarcinoma in women: findings from the canadian national
enhanced cancer surveillance system. Ann Epidemiol. 16:908–916.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Kaneko S, Tamakoshi A, Ohno Y, et al:
Menstrual and reproductive factors and the mortality risk of
gastric cancer in Japanese menopausal females. Cancer Causes
Control. 14:53–59. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Lindblad M, García Rodríguez LA, Chandanos
E and Lagergren J: Hormone replacement therapy and risks of
oesophageal and gastric adenocarcinomas. Br J Cancer. 94:136–141.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Lindblad M, Ye W, Rubio C and Lagergren J:
Estrogen and risk of gastric cancer: a protective effect in a
nationwide cohort study of patients with prostate cancer in Sweden.
Cancer Epidemiol Biomarkers Prev. 13:2203–2207. 2004.PubMed/NCBI
|
|
15.
|
Chandanos E, Lindblad M, Jia C, et al:
Tamoxifen exposure and risk of oesophageal and gastric
adenocarcinoma: a population-based cohort study of breast cancer
patients in Sweden. Br J Cancer. 95:118–122. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Matsuyama Y, Tominaga T, Nomura Y, et al:
Second cancers after adjuvant tamoxifen therapy for breast cancer
in Japan. Ann Oncol. 11:1537–1543. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Duell EJ, Travier N, Lujan-Barroso L, et
al: Menstrual and reproductive factors, exogenous hormone use, and
gastric cancer risk in a cohort of women from the European
Prospective Investigation Into Cancer and Nutrition. Am J
Epidemiol. 172:1384–1393. 2010. View Article : Google Scholar
|
|
18.
|
Kong EH, Pike AC and Hubbard RE: Structure
and mechanism of the oestrogen receptor. Biochem Soc Trans.
31:56–59. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Wang Z, Zhang X, Shen P, et al:
Identification, cloning, and expression of human estrogen
receptor-alpha36, a novel variant of human estrogen
receptor-alpha66. Biochem Biophys Res Commun. 336:1023–1027. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Flouriot G, Brand H, Denger S, et al:
Identification of a new isoform of the human estrogen
receptor-alpha (hER-alpha) that is encoded by distinct transcripts
and that is able to repress hER-alpha activation function 1. EMBO
J. 19:4688–4700. 2000. View Article : Google Scholar
|
|
21.
|
Penot G, Le Péron C, Mérot Y, et al: The
human estrogen receptor-alpha isoform hERalpha46 antagonizes the
proliferative influence of hERalpha66 in MCF7 breast cancer cells.
Endocrinology. 146:5474–5484. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kim KH and Bender JR: Rapid, estrogen
receptor-mediated signaling: why is the endothelium so special? Sci
STKE. 2005:pe282005.PubMed/NCBI
|
|
23.
|
Li L, Haynes MP and Bender JR: Plasma
membrane localization and function of the estrogen receptor alpha
variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA.
100:4807–4812. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Moriarty K, Kim KH and Bender JR:
Minireview: estrogen receptor-mediated rapid signaling.
Endocrinology. 147:5557–5563. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Gan L, He J, Zhang X, et al: Expression
profile and prognostic role of sex hormone receptors in gastric
cancer. BMC Cancer. 12:5662012. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Ryu WS, Kim JH, Jang YJ, et al: Expression
of estrogen receptors in gastric cancer and their clinical
significance. J Surg Oncol. 106:456–461. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Deng H, Huang X, Fan J, et al: A variant
of estrogen receptor-alpha, ER-alpha36 is expressed in human
gastric cancer and is highly correlated with lymph node metastasis.
Oncol Rep. 24:171–176. 2010.PubMed/NCBI
|
|
28.
|
Zhang XT, Kang LG, Ding L, et al: A
positive feedback loop of ER-alpha36/EGFR promotes malignant growth
of ER-negative breast cancer cells. Oncogene. 30:770–780. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Wang M, Pan JY, Song GR, et al: Altered
expression of estrogen receptor alpha and beta in advanced gastric
adenocarcinoma: correlation with prothymosin alpha and
clinicopathological parameters. Eur J Surg Oncol. 33:195–201. 2007.
View Article : Google Scholar
|
|
30.
|
Teoh H and Man RY: Progesterone modulates
estradiol actions: acute effects at physiological concentrations.
Eur J Pharmacol. 378:57–62. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Yang L, Xie G, Fan Q and Xie J: Activation
of the hedgehog-signaling pathway in human cancer and the clinical
implications. Oncogene. 29:469–481. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Yeh TS, Wu CW, Hsu KW, et al: The
activated Notch1 signal pathway is associated with gastric cancer
progression through cyclooxygenase-2. Cancer Res. 69:5039–5048.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Zhang XT, Ding L, Kang LG and Wang ZY:
Involvement of ER-alpha36, Src, EGFR and STAT5 in the biphasic
estrogen signaling of ER-negative breast cancer cells. Oncol Rep.
27:2057–2065. 2012.PubMed/NCBI
|
|
34.
|
Frame MC: Src in cancer: deregulation and
consequences for cell behaviour. Biochim Biophys Acta.
1602:114–130. 2002.PubMed/NCBI
|
|
35.
|
Chiang GG and Sefton BM: Phosphorylation
of a Src kinase at the autophosphorylation site in the absence of
Src kinase activity. J Biol Chem. 275:6055–6058. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Xu W, Harrison SC and Eck MJ:
Three-dimensional structure of the tyrosine kinase c-Src. Nature.
385:595–602. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Xu W, Doshi A, Lei M, et al: Crystal
structures of c-Src reveal features of its autoinhibitory
mechanism. Mol Cell. 3:629–638. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Sherr CJ: D-type cyclins. Trends Biochem
Sci. 20:187–190. 1995. View Article : Google Scholar
|
|
39.
|
Sauter ER, Yeo UC, von Stemm A, et al:
Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer
Res. 62:3200–3206. 2002.PubMed/NCBI
|
|
40.
|
Udhayakumar G, Jayanthi V, Devaraj N and
Devaraj H: Interaction of MUC1 with beta-catenin modulates the Wnt
target gene cyclinD1 in H. pylori-induced gastric cancer. Mol
Carcinog. 46:807–817. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Arber N, Gammon MD, Hibshoosh H, et al:
Overexpression of cyclin D1 occurs in both squamous carcinomas and
adenocarcinomas of the esophagus and in adenocarcinomas of the
stomach. Hum Pathol. 30:1087–1092. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Motohashi M, Wakui S, Muto T, et al:
Cyclin D1/cdk4, estrogen receptors α and β, in
N-methyl-N’-nitro-N-nitrosoguanidine-induced rat gastric
carcinogenesis: immunohistochemical study. J Toxicol Sci.
36:373–378. 2011.
|
|
43.
|
Zhang X, Ding L, Kang L and Wang ZY:
Estrogen receptor-alpha 36 mediates mitogenic antiestrogen
signaling in ER-negative breast cancer cells. PloS One.
7:e301742012. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Kitaoka H: Sex hormone dependency and
endocrine therapy in diffuse carcinoma of the stomach. Gan To
Kagaku Ryoho. 10:2453–2460. 1983.(In Japanese).
|
|
45.
|
Furukawa H, Iwanaga T, Koyama H and
Taniguchi H: Effect of sex hormones on the experimental induction
of cancer in rat stomach - a preliminary study. Digestion.
23:151–155. 1982. View Article : Google Scholar : PubMed/NCBI
|
